NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

594 hedge funds and large institutions have $12.9B invested in Neurocrine Biosciences in 2024 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 211 increasing their positions, 209 reducing their positions, and 73 closing their positions.

Holders
594
Holders Change
+26
Holders Change %
+4.58%
% of All Funds
7.91%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
112
Increased
211
Reduced
209
Closed
73
Calls
$48M
Puts
$44.2M
Net Calls
+$3.78M
Net Calls Change
-$1.62M

Top Buyers

1
Dodge & Cox
1
Dodge & Cox
California
$412M
2
Raymond James Financial
2
Raymond James Financial
Florida
$115M
3
Citadel Advisors
3
Citadel Advisors
Florida
$346M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$199M
5
Thrivent Financial for Lutherans
5
Thrivent Financial for Lutherans
Minnesota
$101M

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$19.8M
2
JAM
2
Jupiter Asset Management
United Kingdom
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$9.17M
4
DM
4
Deerfield Management
New York
$118M
5
Amundi
5
Amundi
France
$36.3M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$2.02B 14,782,722 +526,674 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.38B 10,119,641 +122,681 +1%
State Street
3
State Street
Massachusetts
$668M 4,891,137 -257,156 -5%
Dodge & Cox
4
Dodge & Cox
California
$412M 3,016,425 +1,728,605 +134%
Citadel Advisors
5
Citadel Advisors
Florida
$346M 2,538,109 +773,519 +44%
Renaissance Technologies
6
Renaissance Technologies
New York
$340M 2,489,397 -85,149 -3%
AQR Capital Management
7
AQR Capital Management
Connecticut
$259M 1,896,891 +53,610 +3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$256M 1,875,062 +15,830 +0.9%
BG
9
Bellevue Group
Switzerland
$248M 1,820,000 -43,800 -2%
Morgan Stanley
10
Morgan Stanley
New York
$215M 1,573,297 +223,916 +17%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$203M 1,490,513 -184,663 -11%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$199M 1,457,425 +739,199 +103%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$187M 1,371,186 -126,745 -8%
UBS AM
14
UBS AM
Illinois
$146M 1,070,096 +175,879 +20%
Goldman Sachs
15
Goldman Sachs
New York
$134M 983,799 -33,355 -3%
Northern Trust
16
Northern Trust
Illinois
$134M 981,939 +210,315 +27%
Invesco
17
Invesco
Georgia
$130M 949,512 +74,847 +9%
BNP Paribas Asset Management
18
BNP Paribas Asset Management
France
$129M 944,738 +124,770 +15%
O
19
OrbiMed
New York
$128M 938,120 +635,900 +210%
DCP
20
DSM Capital Partners
Florida
$127M 932,595 -11,559 -1%
B
21
Braidwell
Connecticut
$123M 901,790 -15,884 -2%
Brown Advisory
22
Brown Advisory
Maryland
$123M 898,293 -43,854 -5%
AC
23
Armistice Capital
New York
$122M 892,000 +710,619 +392%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$119M 870,290 +12,040 +1%
DM
25
Deerfield Management
New York
$118M 862,000 -454,590 -35%
1
2 3 4 5